1040449-01-1Relevant articles and documents
Chemo-enzymatic synthesis of a series of 2,4-syn-functionalized (S)-glutamate analogues: New insight into the structure-activity relation of ionotropic glutamate receptor subtypes 5, 6, and 7
Sagot, Emanuelle,Pickering, Darryl S.,Pu, Xiaosui,Umberti, Michelle,Stensb?l, Tine B.,Nielsen, Birgitte,Chapelet, Marion,Bolte, Jean,Gefflaut, Thierry,Bunch, Lennart
, p. 4093 - 4103 (2008)
(S)-Glutamic acid (Glu) is the major excitatory neurotransmitter in the central nervous system (CNS) activating the plethora of ionotropic Glu receptors (iGluRs) and metabotropic Glu receptors (mGluRs). In this paper, we present a chemo-enzymatic strategy for the enantioselective synthesis of five new Glu analogues 2a-f (2d is exempt) holding a functionalized substituent in the 4-position. Nine Glu analogues 2a-j are characterized pharmacologically at native 2-amino-3-(3-hydroxy-5-methyl-4-isoxazolyl)propionic acid (AMPA), kainic acid (KA), and N-methyl-D-aspartic acid (NMDA) receptors in rat synaptosomes as well as in binding assays at cloned rat iGluR5-7 subtypes. A detailed in silico study address as to why 2h is a high-affinity ligand at iGluR57 (Ki = 3.81, 123, 57.3 nM, respectively), while 2e is only a high affinity ligand at iGluR5 (Ki = 42.8 nM). Furthermore, a small series of commercially available iGluR ligands are characterized in iGluR5-7 binding.
Chemo-enzymatic synthesis of (2S,4R)-2-amino-4-(3-(2,2-diphenylethylamino)- 3-oxopropyl)pentanedioic acid: A novel selective inhibitor of human excitatory amino acid transporter subtype 2
Sagot, Emanuelle,Jensen, Anders A.,Pickering, Darryl S.,Pu, Xiaosui,Umberti, Michelle,Stensb?l, Tine B.,Nielsen, Birgitte,Assaf, Zeinab,Aboab, Bétina,Bolte, Jean,Gefflaut, Thierry,Bunch, Lennart
experimental part, p. 4085 - 4092 (2009/05/30)
In the mammalian central nervous system (CNS), the action of sodium dependent excitatory amino acid transporters (EAATs) is responsible for termination of glutamatergic neurotransmission by reuptake of (S)-glutamate (Glu) from the synaptic cleft. Five EAAT subtypes have been identified, of which EAAT1-4 are present in the CNS, while EAAT5 is localized exclusively in the retina. In this study, we have used an enantioselective chemo-enzymatic strategy to synthesize 10 new Glu analogues 2a-k (2d is exempt) with different functionalities in the 4R-position and characterized their pharmacological properties at the human EAAT1-3. In particular, one compound, 2k, displayed a significant preference as inhibitor of the EAAT2 subtype over EAAT1,3. The compound also displayed very low affinities toward ionotropic and metabotropic Glu receptors, making it the most selective EAAT2 inhibitor described so far.
